MicroMed DeBakey Trial Ready To Begin Following CMS Payment Change

CMS' decision to reimburse axial flow left-ventricular assist devices at the same rate as positive displacement LVADs resulted from meetings between the agency and system developers and researchers, MicroMed says

More from Archive

More from Medtech Insight